The prevalence of hypersomnia disorders — neurologic conditions characterized by bouts of sleepiness — is grossly underestimated. The shortage of effective therapies may be eased by several new clinical drug trials.
In Narcolepsy With Cataplexy, a New Form of Sodium Oxybate Promises Better Long-Term Safety
A new lower-sodium product is the latest in a wave of novel therapies with differing mechanisms of action that are improving quality of life for people with narcolepsy and its associated symptoms.
Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial
A long-term study has confirmed the durability of benefits and safety of a newly FDA-approved drug to treat excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea.